文献速递胃肠外科围术期管理与 ERAS

机构手术量对机器人直肠癌手术结局的影响

Association of institutional volume with surgical and oncologic outcomes for robotic rectal cancer surgery: a retrospective review.
PubMed 文献 · Surg Endosc · 2026-08-06

基于美国国家癌症数据库(2010-2022)的回顾性研究,比较低、中、高手术量机构机器人直肠癌手术的围手术期和肿瘤学结局。高手术量机构中转开腹率、90天死亡率和淋巴结检出≥12枚的比例更优,但多因素分析显示机构手术量与长期总生存无显著差异。

要点

  • 高手术量机构中转开腹率更低(3.2% vs 7.9%),90天死亡率更低(1.3% vs 2.2%)。
  • 高手术量机构更常检出≥12枚淋巴结(85.7% vs 76.8%)。
  • 多因素分析显示机构手术量与长期总生存无显著差异。

核心结论

  • 高手术量机构的机器人直肠癌手术围手术期和肿瘤学结局更优,但长期总生存无显著差异。

研究设计与样本

  • 回顾性研究,使用美国国家癌症数据库2010-2022年数据,纳入327家机构中接受机器人直肠癌切除术的成人患者。

主要发现

  • 低、中、高手术量机构的中转开腹率分别为7.9%、5.2%、3.2%(p<0.0001)。
  • 低、中、高手术量机构的90天死亡率分别为2.2%、1.4%、1.3%(p<0.0001)。
  • 低、中、高手术量机构淋巴结检出≥12枚的比例分别为76.8%、80.5%、85.7%(p<0.0001)。

临床怎么用

  • 低、中手术量机构可通过优化患者选择和围手术期管理来改善机器人直肠癌手术的长期肿瘤学结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Robotic surgery has been increasingly adopted for rectal cancer. However, the majority of studies investigating robotic surgery have focused on high-volume institutions. This study aims to compare the perioperative and oncologic outcomes of robotic rectal cancer surgery at low-, medium-, and high-volume institutions. METHODS: Adults undergoing robotic proctectomy for primary rectal cancer were identified from the National Cancer Database (2010-2022). Institutions reporting ≥ 2 years of cases were included. A generalized additive model was used to determine volume thresholds classifying hospitals into low, medium, and high volume based on their rates of conversion to open surgery. Patient characteristics and outcomes were evaluated with chi-squared analysis. Overall survival was assessed with multivariable Cox proportional hazards modeling. RESULTS: Among 327 institutions, thresholds for low, medium, and high were 1-4, 5-13, and > 13 cases/year. The total number of patients and facilities for low, medium, and high were 10,945/142, 17,361/147, and 8,828/38, respectively. High-volume institutions (HVIs) operated more frequently on cN1-2 tumors (46.0, 50.0, 53.5%, p < 0.0005), but fewer poorly differentiated tumors (10.2, 9.8, 8.4%, p < 0.0003). HVIs had lower rates of conversion to open (7.9, 5.2, 3.2%, p < 0.0001), lower 90-day mortality (2.2, 1.4, 1.3, p < 0.0001), and more frequently resected ≥ 12 lymph nodes (76.8, 80.5, 85.7%, p < 0.0001). On multivariable analysis, there was no difference in long-term overall survival based on institutional volume (medium vs. low: HR 0.97 [0.88-1.07], p = 0.52; high vs. low: HR 0.92 [0.82-1.03], p = 0.13). CONCLUSIONS: Differences in patient selection exist for robotic rectal cancer resection based on hospital volume. HVIs demonstrated better oncologic and perioperative outcomes, but there was no difference in long-term overall survival based on volume. There is an opportunity for low- and medium-volume institutions to achieve appropriate long-term oncologic outcomes, but further work is needed to investigate patient selection and early post-operative mortality.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. El-Farra MH, Ji L, Lee J, et al. Association of institutional volume with surgical and oncologic outcomes for robotic rectal cancer surgery: a retrospective review. Surg Endosc. 2026. PMID: 42560485. doi:10.1007/s00464-026-13234-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。